TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RCKT

Rocket Pharmaceuticals Inc

Healthcare · Biotechnology

3.40$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Rocket Pharmaceuticals Inc (RCKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 330 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCKT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.5 113 130 102 251 372 591 497 552 566 528 330
3.6 112 128 101 209 308 487 392 364 378 378 193
3.6 80 30 79 111 185 297 233 141 56 164 78
3.6 111 126 100 206 304 483 389 356 373 372 189
0.0 0.0 0.0
0.8 1.1 0.6 2.0 29 19 72 78
0.0 0.0 0.0 31 31 31 31 39 39 39 39
0.0 0.0 0.0 0.2 26 25 25 25
57 4.5 56 54 57 65 87 42 62 74 64 53
3.7 4.1 7.2 4.1 15 18 33 22 39 49 41 30
5.1 0.0 0.0 1.0 7.1 2.6 2.5 2.7 2.9 2.9
1.1 1.6 1.6 0.5 0.0 0.0 0.0 0.0 37 0.0 1.6
2.6 0.0 49 50 41 45 35
-52 109 73 48 194 307 504 455 490 493 463 277
-128 -196 -239 -268 -106 -183 -323 -492 -714 -959 -1,218 -1,441
2.1 6.6 6.7 6.8 39 49 55 63 68 84 95 111

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?